| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/28/2011 | CN101455648B Puerarin freeze-drying preparation |
| 09/28/2011 | CN101417114B Traditional Chinese medicine for treating hypertension and high blood-fat |
| 09/28/2011 | CN101406627B Chinese medicine powder for treating diabetic |
| 09/28/2011 | CN101342257B Medicament for treating hyperlipemia and preparation method thereof |
| 09/28/2011 | CN101313942B Chinese medicine composition for treating nephropathy |
| 09/28/2011 | CN101306086B Broussonetia papyrifera leaves health obesity attenuation capsule and its preparation method |
| 09/28/2011 | CN101279038B Chinese medicine for treating diabetes |
| 09/27/2011 | US8026272 Modified lysine-mimetic compounds |
| 09/27/2011 | US8026240 Octahydro-pyrrolo[3,4-b]pyrrole N-oxides |
| 09/27/2011 | US8026212 Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/27/2011 | CA2615611C Indazole derivatives |
| 09/27/2011 | CA2608848C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 09/27/2011 | CA2475930C 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 09/27/2011 | CA2457410C Compounds effecting glucokinase |
| 09/27/2011 | CA2440042C Carboxamide derivatives as therapeutic agents |
| 09/27/2011 | CA2370206C Pharmaceutical compositions for inhibition of cytokine production and secretion |
| 09/25/2011 | CA2735107A1 Co-precipitated salts of fatty acids |
| 09/22/2011 | WO2011116216A2 Topical skin care composition |
| 09/22/2011 | WO2011115447A2 C-terminal truncated peroxiredoxin-ii, and composition for preventing and treating apoptosis containing same |
| 09/22/2011 | WO2011115183A1 Novel monocyclic pyrimidine derivative |
| 09/22/2011 | WO2011115106A1 Pharmaceutical for pseudo-exercise therapy |
| 09/22/2011 | WO2011114271A1 2,3 dihydro-1h-inden-1-yl- 2,7-diazaspiro [3.6] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor |
| 09/22/2011 | WO2011113947A1 Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions |
| 09/22/2011 | WO2011094731A3 Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus |
| 09/22/2011 | WO2011088806A3 A method of industrial production of an amorphous form of atorvastatin with a high specific surface area and its use in a dosage form |
| 09/22/2011 | WO2011050263A3 Systemic immunosuppression in the treatment of age related macular degeneration and diabetic retinopathy |
| 09/22/2011 | WO2010053471A8 Modulators of atp-binding cassette transporters |
| 09/22/2011 | US20110230568 Heating of polymers and other materials using radiation for drug delivery and other applications |
| 09/22/2011 | US20110230555 Enzyme Inhibitors and the Use Thereof |
| 09/22/2011 | US20110230544 Modulation of c-reactive protein expression |
| 09/22/2011 | US20110230542 Compositions and Methods for Inhibiting Expression of the PCSK9 Gene |
| 09/22/2011 | US20110230529 Benzamide glucokinase activators |
| 09/22/2011 | US20110230521 Pyrazole Compounds As CCR1 Antagonists |
| 09/22/2011 | US20110230520 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
| 09/22/2011 | US20110230519 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 09/22/2011 | US20110230516 CCR1 Antagonists and Methods of Use Therefor |
| 09/22/2011 | US20110230511 Carboxamide bioisosteres of opiates |
| 09/22/2011 | US20110230507 Piperidine GPCR Agonists |
| 09/22/2011 | US20110230501 Pharmaceutical compositions for the treatment of diabetes mellitus |
| 09/22/2011 | US20110230495 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds |
| 09/22/2011 | US20110230494 Heteroaryl compounds and uses thereof |
| 09/22/2011 | US20110230493 1-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH Inhibitors |
| 09/22/2011 | US20110230485 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/22/2011 | US20110230484 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators |
| 09/22/2011 | US20110230482 Compounds modulating c-fms and/or c-kit activity |
| 09/22/2011 | US20110230481 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a method of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 09/22/2011 | US20110230480 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 09/22/2011 | US20110230477 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders |
| 09/22/2011 | US20110230470 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors |
| 09/22/2011 | US20110230464 Purine derivatives useful as p13 kinase inhibitors |
| 09/22/2011 | US20110230462 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230461 2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives |
| 09/22/2011 | US20110230459 Lactam acetamides as calcium channel blockers |
| 09/22/2011 | US20110230458 Phenyl-heteroaryl derivatives and methods of use thereof |
| 09/22/2011 | US20110230452 Compounds and methods for the treatment of pain and other diseases |
| 09/22/2011 | US20110230451 Identification and use of compounds that affect the fidelity of eukaryotic translation initiation codon selection |
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
| 09/22/2011 | US20110230445 Substituted Heteroaryls |
| 09/22/2011 | US20110230439 Methods of reducing absorption of trans fatty acids using water-soluble cellulose derivatives |
| 09/22/2011 | US20110230435 Methods and Compositions for Treating Obesity and Related Disorders |
| 09/22/2011 | US20110230426 Template-fixed peptidomimetics |
| 09/22/2011 | US20110230414 Pyrrolopyrazine Kinase Inhibitors |
| 09/22/2011 | US20110230404 Glycoproteins Produced in Plants and Methods of Their Use |
| 09/22/2011 | US20110230403 Glycoside derivatives and uses thereof |
| 09/22/2011 | US20110230402 Treating diabetes melitus using insulin injections with less than daily injection frequency |
| 09/22/2011 | US20110230401 Insulin fusion polypeptides |
| 09/22/2011 | US20110230400 Nutritional composition for wound healing |
| 09/22/2011 | US20110230399 Methods for Treating Obesity Related Disease |
| 09/22/2011 | US20110230398 Apolipoprotein C-II or its active fractions for the prevention or treatment of obesity and related metabolic disorders |
| 09/22/2011 | US20110229944 FAD4, FAD5, FAD5-2, AND FAD6, Novel Fatty Acid Desaturase Family Members and Uses Thereof |
| 09/22/2011 | US20110229587 Calcium Supplements for the Treatment of Diabetes |
| 09/22/2011 | US20110229578 Modafinil oral lyophilizate |
| 09/22/2011 | US20110229577 Biologically active silicic acid |
| 09/22/2011 | US20110229573 Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form |
| 09/22/2011 | US20110229571 Pharmaceutical Compositions Comprising a Selective I1 Imidazoline Receptor Agonist and an Angiotensin II Receptor Blocker |
| 09/22/2011 | US20110229568 Michael systems as transglutaminase inhibitors |
| 09/22/2011 | US20110229559 Drug Release From Nanoparticle-Coated Capsules |
| 09/22/2011 | US20110229538 Topical skin care composition |
| 09/22/2011 | US20110229525 Modulation of cytokine signaling |
| 09/22/2011 | US20110229521 Nutritional support of the immune system during anti-cancer treatment |
| 09/22/2011 | US20110229496 Method for regulating survival and memory of t helper 1 cells |
| 09/22/2011 | US20110229490 Lyophilized Formulations of Engineered Anti-IL-23p19 Antibodies |
| 09/22/2011 | US20110229489 Antibodies with pH Dependent Antigen Binding |
| 09/22/2011 | US20110229487 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient |
| 09/22/2011 | US20110229476 Monospecific and multispecific antibodies and method of use |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229461 PD-1 Antibodies |
| 09/22/2011 | US20110229423 Pacap signaling pathway modulators for treating inflammatory skin diseases having a neurogenic component, notably rosacea, and compositions comprised thereof |
| 09/22/2011 | US20110229418 Compositions and Methods of Treating and Preventing Lung Cancer |
| 09/22/2011 | US20110229409 Linkable lewis x analogs |
| 09/22/2011 | US20110226650 Antibody formulation |
| 09/22/2011 | DE102010012232A1 New imidazole useful in pharmaceutical preparation e.g. for prevention or treatment of cancer diseases, pathological effects of alcohol misuse, viral hepatitis, steatohepatitis, acute and chronic pancreatitis, toxic renal diseases |
| 09/22/2011 | DE102010011919A1 Liquid composition, useful for treating e.g. type II diabetes mellitus, and/or obesity, comprises a glucagon-like peptide-1 agonist and/or its salt e.g. exendin-4, optionally an adjuvant and methionine |
| 09/22/2011 | CA2792857A1 Topical skin care composition |
| 09/22/2011 | CA2792733A1 Fat-binding compositions comprising .alpha.- or .beta.-cyclodextrin |
| 09/22/2011 | CA2792234A1 2,3 dihydro-1h-inden-1-yl-2,7-diazaspiro [3.5] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor |
| 09/21/2011 | EP2366774A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366773A2 PUFA polyketide synthase systems and uses thereof |
| 09/21/2011 | EP2366772A2 PUFA polyketide synthase systems and uses thereof |